Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase - PubMed (original) (raw)
. 1995 Jan 6;270(1):319-24.
doi: 10.1074/jbc.270.1.319.
Affiliations
- PMID: 7529227
- DOI: 10.1074/jbc.270.1.319
Free article
Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
J K Liao et al. J Biol Chem. 1995.
Free article
Abstract
The atherogenic effects of low-density lipoprotein (LDL) may be mediated, in part, by its effect(s) on endothelial-derived nitric oxide (NO). To determine whether LDL can modulate NO production by changing NO synthase expression, we treated human saphenous vein endothelial cells with increasing concentrations of native or oxidized LDL (0-100 micrograms/ml) for various durations (0-72 h). Oxidized, but not native LDL caused a time-dependent decrease in steady-state NO synthase mRNA levels. This coincided with a maximal 56% decrease in NOS activity was determined by [3H]arginine to [3H]citrulline conversion. In the presence of actinomycin D, treatment with oxidized LDL reduced the half-life of NO synthase mRNA from 36 to 10 h. This decrease in NO synthase mRNA correlated with the degree of LDL oxidation and was attenuated by pretreatment with cycloheximide. Nuclear run-off studies showed a biphasic transcriptional pattern of NO synthase gene with an initial 25% decrease during the first 6 h followed by a maximal 2.2-fold increase over baseline during the subsequent 18 h. These results indicate that oxidized LDL regulates endothelial NOS expression through a combination of early transcriptional inhibition and post-transcriptional mRNA destabilization.
Similar articles
- Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells.
Vidal F, Colomé C, Martínez-González J, Badimon L. Vidal F, et al. Eur J Biochem. 1998 Mar 15;252(3):378-84. doi: 10.1046/j.1432-1327.1998.2520378.x. Eur J Biochem. 1998. PMID: 9546652 - Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase.
Nuszkowski A, Gräbner R, Marsche G, Unbehaun A, Malle E, Heller R. Nuszkowski A, et al. J Biol Chem. 2001 Apr 27;276(17):14212-21. doi: 10.1074/jbc.M007659200. Epub 2001 Jan 22. J Biol Chem. 2001. PMID: 11278358 - Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel.
Tai SC, Robb GB, Marsden PA. Tai SC, et al. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):405-12. doi: 10.1161/01.ATV.0000109171.50229.33. Epub 2003 Dec 1. Arterioscler Thromb Vasc Biol. 2004. PMID: 14656742 Review. - Oxidized lipoproteins and nitric oxide.
Jessup W. Jessup W. Curr Opin Lipidol. 1996 Oct;7(5):274-80. doi: 10.1097/00041433-199610000-00003. Curr Opin Lipidol. 1996. PMID: 8937516 Review.
Cited by
- On the epigenetics of vascular regulation and disease.
Schleithoff C, Voelter-Mahlknecht S, Dahmke IN, Mahlknecht U. Schleithoff C, et al. Clin Epigenetics. 2012 May 23;4(1):7. doi: 10.1186/1868-7083-4-7. Clin Epigenetics. 2012. PMID: 22621747 Free PMC article. - The effect of polymorphisms of MTHER gene and vitamin B on hyperhomocysteinemia.
Chen J, Zhang I, Cheng L, Li Y. Chen J, et al. J Tongji Med Univ. 2001;21(1):17-20. doi: 10.1007/BF02888026. J Tongji Med Univ. 2001. PMID: 11523237 - Effects of exercise training and detraining on cutaneous microvascular function in man: the regulatory role of endothelium-dependent dilation in skin vasculature.
Wang JS. Wang JS. Eur J Appl Physiol. 2005 Jan;93(4):429-34. doi: 10.1007/s00421-004-1176-4. Epub 2004 Oct 14. Eur J Appl Physiol. 2005. PMID: 15490222 Clinical Trial. - Targeting nitric oxide with drug therapy.
Mason RP, Cockcroft JR. Mason RP, et al. J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):40-52. doi: 10.1111/j.1524-6175.2006.06041.x. J Clin Hypertens (Greenwich). 2006. PMID: 17170605 Free PMC article. Review. - Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ, Chew GT, Watts GF. Woodman RJ, et al. Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources